Literature DB >> 12966592

CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis.

Riikka Nissinen1, Marjatta Leirisalo-Repo, Minna Tiittanen, Heikki Julkunen, Hanna Hirvonen, Timo Palosuo, Outi Vaarala.   

Abstract

OBJECTIVE: To characterize cytokine and chemokine receptor profiles of T cells and monocytes in inflamed synovium and peripheral blood (PB) in patients with rheumatoid arthritis (RA) and other arthritides.
METHODS: We studied PB and synovial fluid (SF) samples taken from 20 patients with RA and 9 patients with other arthritides. PB cells from 8 healthy adults were used as controls. CCR3, CCR5, and intracellular interferon-g (IFN-g) and interleukin 4 (IL-4) expression in CD8+ and CD8- T cell populations and in CD14+ cells were determined with flow cytometry.
RESULTS: Expression of CCR5 and CCR3 by CD8-, CD8+ T cells and CD14+ monocytes was increased in SF compared to PB cells in patients with RA and other arthritides. The number of CD8+ T cells spontaneously expressing IL-4 and IFN-g was higher in SF than in PB in RA patients. Spontaneous CCR5 expression was associated with intracellular IFN-g expression in CD8+ T cells derived from SF in RA. In CD8- T cells the ratio of CCR5+/CCR3+ cells was increased in patients with RA compared to patients with other arthritides. The number of PB CD8- T cells expressing IFN-g after mitogen stimulation was higher in controls than in patients. In PB monocytes the ratio of CCR5+/CCR3+ cells was increased in patients with RA compared to patients with other arthritides and controls.
CONCLUSION: T cells and monocytes infiltrating joints in RA and in other arthritides showed increased activation of both type 1 and type 2 immune markers. More pronounced type 1 immune response in joints, shown as an increased CCR5/CCR3 ratio, was found in the patients with RA versus those with other arthritides. Monocytes but not T cells in PB showed increased activation in RA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966592

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.

Authors:  Chen Lina; Wang Conghua; Leng Nan; Zhu Ping
Journal:  J Clin Immunol       Date:  2011-05-12       Impact factor: 8.317

2.  Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes.

Authors:  Susanne Skarsvik; Johnny Ludvigsson; Outi Vaarala
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

3.  Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema.

Authors:  Bing Ma; Min-Jong Kang; Chun Geun Lee; Svetlana Chapoval; Wei Liu; Qingsheng Chen; Anthony J Coyle; José M Lora; Dominic Picarella; Robert J Homer; Jack A Elias
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808

4.  Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease.

Authors:  Hanne Rintamäki; Taina Sipponen; Harri-M Salo; Outi Vaarala; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

5.  Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.

Authors:  A C Borczuk; N Papanikolaou; R L Toonkel; M Sole; L A Gorenstein; M E Ginsburg; J R Sonett; R A Friedman; C A Powell
Journal:  Oncogene       Date:  2007-07-23       Impact factor: 9.867

6.  Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis.

Authors:  Matthias Wahle; Gesine Hanefeld; Stephan Brunn; Rainer H Straub; Ulf Wagner; Andreas Krause; Holm Häntzschel; Christoph G O Baerwald
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

7.  Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis.

Authors:  Yunzhi Xu; Qi Zhu; Jinglve Song; Hongli Liu; Yutong Miao; Fan Yang; Feiyan Wang; Wenjing Cheng; Yebin Xi; Xiaoyin Niu; Dongyi He; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2015-12-02       Impact factor: 4.711

8.  Elevated ACKR2 expression is a common feature of inflammatory arthropathies.

Authors:  Helen M Baldwin; Mark D Singh; Veronica Codullo; Vicky King; Hilary Wilson; Iain McInnes; Gerard J Graham
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

9.  Rheumatoid arthritis synovial fibroblasts promote TREM-1 expression in monocytes via COX-2/PGE2 pathway.

Authors:  Anping Peng; Xinyi Lu; Jun Huang; Min He; Jianhua Xu; Hui Huang; Qubo Chen
Journal:  Arthritis Res Ther       Date:  2019-07-08       Impact factor: 5.156

10.  GTS-21, an α7-nicotinic acetylcholine receptor agonist, modulates Th1 differentiation in CD4+ T cells from patients with rheumatoid arthritis.

Authors:  Shiyao Wu; Hongjun Zhao; Hui Luo; Xianzhong Xiao; Huali Zhang; Tong Li; Xiaoxia Zuo
Journal:  Exp Ther Med       Date:  2014-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.